Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Aquadex System in Patients With Heart Failure and Fluid Overload

NCT05318105 is registered in ClinicalTrials.gov with Nuwellis, Inc. as lead sponsor.

NCT NCT05318105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05318105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Aquadex System in Patients With Heart Failure and Fluid Overload
Lead sponsor
Nuwellis, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
June 28, 2022
Completion date
April 7, 2026
Enrollment
167 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

fluid overload, heart failure, heart failure (for example, fluid overload)